Mouse anti Human Matrix Metalloproteinase 2 (MMP2)

CAT:
579-X2054M
Size:
200 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Mouse anti Human Matrix Metalloproteinase 2 (MMP2) - image 1

Mouse anti Human Matrix Metalloproteinase 2 (MMP2)

  • Background:

    The matrix metalloproteinases (MMP) are a family of peptidase enzymes responsible for the degradation of extracellular matrix components, including collagen, gelatin, fibronectin, laminin and proteoglycan. Transcription of MMP genes is differentially activated by phorbol ester, lipopolysaccharide (LPS) or staphylococcal enterotoxin B (SEB). MMP catalysis requires both calcium and zinc. MMP-2 (also designated type IV collagenase) cleaves Collagen Types IV, V, VII and X and gelatin type I. Activation of MMP-2 secretion requires the Ras signaling pathway.
  • Synonyms:

    MMP2, MMP-2, CLG4, CLG4A, Matrix metallopeptidase 2, 72 kDa Type IV collagenase precursor, 72 kDa gelatinase, Gelatinase A
  • UniProt:

    P08253 (Human)
  • Host:

    Mouse
  • Species Reactivity:

    Human
  • Isotype:

    IgG1
  • Clone:

    4D3
  • Conjugation:

    Unconjugated
  • Type:

    Monoclonal Antibody
  • Applications:

    WB, ELISA, IHC
  • Field of Research:

    Cellular Structures
  • Purification Method:

    Protein A/G Chromatography
  • Assay Principle:

    Antibody can be used for Western blotting (1-2 µg/mL) and immunohistochemistry on formLin-fixed paraffin-embedded tissue sections (1-5 µg/mL). Optimal concentration should be evaluated by serial dilutions.
  • Stability:

    See expiration date on vial
  • Concentration:

    See vial for Concentration
  • Form:

    Provided as solution in phosphate buffered saline with 0,08% sodium azide
  • Precautions:

    This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving Humans or animals.
  • References & Citations:

    1. Talvensaari-Mattila, A., et al. (2005). Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma. Anticancer Res. 25(6B);4101-4105. 2. Honkavuori, M., et al. (2007). MMP-2 expression associates with CA125 and clinical course in endometrial carcinoma. Gynecol. Oncol. 104(1);217-221.
  • Shipping Conditions:

    Ambient Temperature, freeze upon arrival
  • Storage Conditions:

    Product should be stored at -20ºC; Aliquot to avoid freeze/thaw cycles
  • Functional Analysis:

    WB
  • CAS Number:

    9007-83-4